The medical services app developer welcomed Baidu Capital aboard in a series C-plus round that represents its second nine-figure round.
Internet group Baidu led a $100m series C-plus round for China-based healthcare access software provider Weimai yesterday through growth-stage investment arm Baidu Capital, DealStreetAsia reported, citing a company statement.
Venture capital group IDG Capital, VC fund Vision Plus Capital, healthcare investment firm Cenova Capital and VC firms Matrix Partners China and Source Code Capital also took part in the round.
Weimai has built a software platform that utilises big data and artificial intelligence tools as well as telemedicine and disease…
